Pharma Industry News

A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.

swissinfo.ch - Aylin Elçi - Explainer: Watches win, pharma waits as Swiss-India trade deal turns one
Explainer: Watches win, pharma waits as Swiss-India trade deal turns one
www.swissinfo.ch –

The promise of zero tariffs on Swiss watches in India within the next five years fuelled high spirits at a mid-September gathering of Indian and Swiss entrepreneurs hosted by the Geneva Chamber of Commerce (CCIG). In 2025, Switzerland exported…

rediff.com - Nandita Malik - GST Council Approves ITC for Pharma Free Samples & Expired Goods from FY28
GST Council Approves ITC for Pharma Free Samples & Expired Goods from FY28
Rediff.com –

The GST Council has approved a significant reform, allowing pharmaceutical companies to claim Input Tax Credit on free samples and goods destroyed due to expiry from the next fiscal year, a move set to boost manufacturing, liquidity, and exports in…

smh.com.au - Rachel Rasker - No such thing as a free lunch: Doctors 'heavily influenced' by pharma freebies, major review finds
No such thing as a free lunch: Doctors 'heavily influenced' by pharma freebies, major review finds
The Sydney Morning Herald –

Money and meals given to doctors by pharmaceutical companies increased inappropriate prescribing, leaving patients with drugs that were more expensive, had fewer benefits or were not clinically necessary, a major global review finds. The…

247wallst.com - Vandita Jadeja - Cantor Fitzgerald Lifts Price Targets on Four Pharma Giants Amid Mixed Growth Outlooks
Cantor Fitzgerald Lifts Price Targets on Four Pharma Giants Amid Mixed Growth Outlooks
24/7 Wall St –

Cantor Fitzgerald just bumped price targets on Eli Lilly, AbbVie, Merck, and Pfizer, but higher targets do not mean equal conviction. The firm's split between Overweight and Neutral ratings reveals a sharp divide in where analysts see real upside…

marketbeat.com - Spyglass Pharma (NASDAQ:SGP) Shares Gap Up - Still a Buy?
Spyglass Pharma (NASDAQ:SGP) Shares Gap Up - Still a Buy?
MarketBeat –

Spyglass Pharma, Inc. (NASDAQ:SGP - Get Free Report) gapped up before the market opened on Friday. The stock had previously closed at $23.90, but opened at $25.03. Spyglass Pharma shares last traded at $25.2360, with a volume of 1,586 shares.

dailymail.com - Emily Joshu Sterne - Gifts from big pharma influence doctors' prescriptions, study claims
Gifts from big pharma influence doctors' prescriptions, study claims
Mail Online –

Gifts and free dinners from big pharma may influence which drugs your doctor prescribes to treat your health condition, a major review has claimed. Scientists at the Cochrane Collaboration, an organization widely considered to be the 'gold…

thehindubusinessline.com - GST Council permits pharma cos to claim ITC on free samples, goods destroyed upon expiry from FY'28
GST Council permits pharma cos to claim ITC on free samples, goods destroyed upon expiry from FY'28
BusinessLine –

Pharma companies will be able to avail GST input tax credit (ITC) on free samples and on goods destroyed or written off upon expiry of shelf life from the next fiscal year. The GST Council, chaired by Union Finance Minister Nirmala Sitharaman and…

seekingalpha.com - Justin Miller - UnitedHealth: A Beat Is Priced In, But There's Room For Surprise (NYSE:UNH)
UnitedHealth: A Beat Is Priced In, But There's Room For Surprise (NYSE:UNH)
Seeking Alpha –

UnitedHealth Group is rated a conditional Buy, with upside if management raises 2026 guidance and confirms durable margin improvements at the Q3 call. UNH's profitability is surging despite flat revenue and shrinking membership, as management…

theguardian.com - Robert Reich - AI and the climate crisis pose existential risks. The law offers a way to reduce them | Robert Reich
AI and the climate crisis pose existential risks. The law offers a way to reduce them | Robert Reich
The Guardian –

The most basic function of government is to protect people from harm. Two growing phenomena – the climate crisis and AI – pose escalating risks of extraordinary harm. The climate crisis is already causing floods, wildfires, drought…

bangordailynews.com - Ethan Andrews - Maine seeks settlement in generic drug price-fixing scheme
Maine seeks settlement in generic drug price-fixing scheme
Bangor Daily News - Bangor Daily News –

Maine Attorney General Aaron Frey on Thursday joined a coalition of 45 states and territories seeking court approval of settlements with three generic drug makers over allegations that they colluded to artificially inflate prices and reduce…

seekingalpha.com - Albert Anthony - Oceaneering: Undersea Robotics Add To Already Diverse Offshore Portfolio Driving Growth
Oceaneering: Undersea Robotics Add To Already Diverse Offshore Portfolio Driving Growth
Seeking Alpha –

Albert Anthony is the pen name of a business author on Amazon and his newest book is 'How To Pick Stocks: 8 Steps For Long-Term Investing with Fundamental & Technical Analysis,' now available as a 2026 edition paperback and Kindle ebook in several…

seekingalpha.com - Albert Anthony - State Street Stock Shines On As A Bet On Quality Among Global Banks (NYSE:STT)
State Street Stock Shines On As A Bet On Quality Among Global Banks (NYSE:STT)
Seeking Alpha –

Albert Anthony is the pen name of a business author on Amazon and his newest book is 'How To Pick Stocks: 8 Steps For Long-Term Investing with Fundamental & Technical Analysis,' now available as a 2026 edition paperback and Kindle ebook in several…

thehindu.com - The Hindu Bureau - Swiss team explores Telangana's innovation ecosystem
Swiss team explores Telangana's innovation ecosystem
The Hindu –

A Swiss delegation led by State Secretary for Economic Affairs of Switzerland Helene Budliger Artieda visited multiple facilities in Hyderabad to get insights into Telangana's innovation ecosystem. The delegation visited spacetech firm Skyroot…

marketbeat.com - Teva Pharmaceutical Industries (NYSE:TEVA) Reaches New 52-Week High - Time to Buy?
Teva Pharmaceutical Industries (NYSE:TEVA) Reaches New 52-Week High - Time to Buy?
MarketBeat –

Teva Pharmaceutical Industries Ltd. (NYSE:TEVA - Get Free Report) shares reached a new 52-week high during trading on Friday. The company traded as high as $41.69 and last traded at $41.2480, with a volume of 2502662 shares. The stock had…

prnewswire.com - Blood Cancer United - Blood Cancer United Presents Inaugural Breakthrough Voice and Breakthrough Rising Leader Awards at First-Ever Night of Champions
Blood Cancer United Presents Inaugural Breakthrough Voice and Breakthrough Rising Leader Awards at First-Ever Night of Champions
Cision PR Newswire –

Created as part of the newly reimagined Breakthroughs Summit, the inaugural Night of Champions celebrates the patients, supporters, researchers, volunteers, donors and partners advancing Blood Cancer United's Bold Goal of adding one million years…

Receive a Daily briefing on Pharma Industry News

Get Started